DeepMed Research

Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy

Phase 2

Conditions: Oropharyngeal Carcinoma

Interventions: Drug: Anti-EGFR monoclonal antibody

First Posted Date: 2020-08-11

Last Posted Date: 2022-04-04

Lead Sponsor: Fudan University

Target Recruit Count: 52

Registration Number: NCT04508829

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Phase 2

Completed

Conditions: Nasopharyngeal Carcinoma

Interventions: Drug: cetuximab (CTX) or nimotuzumab (NTZ)

First Posted Date: 2020-08-11

Last Posted Date: 2022-04-04

Lead Sponsor: Fudan University

Target Recruit Count: 45

Registration Number: NCT04508816

Locations: 🇨🇳
Xiaoshen Wang, Shanghai, China

A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer

Phase 2

Conditions: Recurrent Colorectal Cancer

Interventions: Combination Product: Radiotherapy Combined With Raltitrexed and Irinotecan

First Posted Date: 2020-08-05

Last Posted Date: 2020-08-05

Lead Sponsor: Fudan University

Target Recruit Count: 30

Registration Number: NCT04499586

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer

Phase 2

Conditions: Metastatic Pancreatic Cancer

Interventions: Drug: Camrelizumab
Drug: Nab paclitaxel
Drug: Gemcitabine Injection

First Posted Date: 2020-08-04

Last Posted Date: 2020-08-04

Lead Sponsor: Fudan University

Target Recruit Count: 117

Registration Number: NCT04498689

Locations: 🇨🇳
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

Not yet recruiting

Conditions: NSCLC, Recurrent
NSCLC Stage IV

First Posted Date: 2020-07-30

Last Posted Date: 2020-07-31

Lead Sponsor: Fudan University

Target Recruit Count: 320

Registration Number: NCT04492969

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia

Phase 2

Completed

Conditions: Atypical Endometrial Hyperplasia

Interventions: Drug: Megestrol Acetate
Drug: Rosuvastatin

First Posted Date: 2020-07-29

Last Posted Date: 2024-01-29

Lead Sponsor: Fudan University

Target Recruit Count: 36

Registration Number: NCT04491682

Locations: 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China

Megestrol Acetate Plus Rosuvastatin in Young Women with Early Endometrial Carcinoma

Phase 2

Active, not recruiting

Conditions: Endometrial Carcinoma Stage I

Interventions: Drug: Megestrol Acetate
Drug: Rosuvastatin

First Posted Date: 2020-07-29

Last Posted Date: 2025-03-12

Lead Sponsor: Fudan University

Target Recruit Count: 48

Registration Number: NCT04491643

Locations: 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China

Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

Phase 2

Conditions: Mucosal Melanoma

Interventions: Drug: Toripalimab
Drug: chemotherapy in combination with Endostar

First Posted Date: 2020-07-15

Last Posted Date: 2020-07-15

Lead Sponsor: Fudan University

Target Recruit Count: 31

Registration Number: NCT04472806

Locations: 🇨🇳
Zhiguo Luo, Shanghai, Shanghai, China

Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents

Phase 2

Conditions: Chemotherapy-induced Nausea and Vomiting (CINV)

Interventions: Drug: Granisetron Transdermal Delivery System

First Posted Date: 2020-07-15

Last Posted Date: 2022-04-20

Lead Sponsor: Fudan University

Target Recruit Count: 60

Registration Number: NCT04472143

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

Clinical Study of Imaging Genomics Based on Machine Learning for BCIG

Conditions: Image, Body
Breast Cancer
Molecular Typing
Pathology

Interventions: Procedure: Multidisciplinary cooperative comprehensive treatment

First Posted Date: 2020-07-08

Last Posted Date: 2020-08-21

Lead Sponsor: Fudan University

Target Recruit Count: 1500

Registration Number: NCT04461990

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy